8-K
filed January 25, 2023, 6:59 PM ET
ticker ELV
CIK 0001156039
earnings
confidence high
sentiment positive
materiality 0.75
Elevance Health Q4 GAAP EPS $3.93, adj. $5.23; revenue up 10.1% to $39.7B; FY revenue $155.7B; dividend raised 16%
Elevance Health, Inc.
2022-FY EPS reported
$24.81
revenue$156,595,000,000
- GAAP EPS Q4 $3.93, FY $24.81; adjusted EPS Q4 $5.23, FY $29.07.
- Full-year operating revenue $155.7B (+13.7% YoY); operating gain $8.5B (+12.9%).
- Medical membership 47.5M (+2.2M YoY); growth in Medicaid, commercial fee-based.
- Quarterly dividend raised 16% to $1.48; new annualized rate $5.92 per share.
- Board authorized $5.0B increase to share repurchase program; 2023 guidance: GAAP EPS >$29.80, adjusted >$32.60.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Elevance Health, Inc. reported year ending December 31, 2023 results: EPS greater than $29.80 per share. Guidance initiated.
- Period
- year ending December 31, 2023
- EPS
- greater than $29.80 per share
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
The Company expects GAAP net income to be greater than $29.80 per share in 2023, and adjusted net income to be greater than $32.60 per share.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Elevance Health, Inc. reported year ended December 31, 2022 results: revenue $156 billion, EPS $24.81 per share.
- Period
- year ended December 31, 2022
- Revenue
- $156 billion
- EPS
- $24.81 per share
- Result
- reported results
Exact text from the filing
• Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share • Fourth quarter and full year adjusted net income was $5.23* and $29.07* per share • Full year operating revenue grew 13.7% year-over-year to $156 billion • Full year operating gain grew 12.9% year-over-year to $8.5 billion • Medical enrollment increased 2.2 million members year-over-year to 47.5 million members • Quarterly dividend increased by 16% to $1.48 per share
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Elevance Health, Inc. reported quarter ended December 31, 2022 results: EPS $3.93 per share.
- Period
- quarter ended December 31, 2022
- EPS
- $3.93 per share
- Result
- reported results
Exact text from the filing
GAAP net income was $3.93 per share in the fourth quarter, including net negative adjustment items of $1.30 per share.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.